ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$4.12
+0.18 (+4.57%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+281.1% upside
Low Target
$11.87
Average Target
$15.70
High Target
$22.80
Current Price
$4.12
Current
$4.12
$4.12
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Scenario Analysis
Bear Case
$11.87
188.1%
Low target
Base Case
$15.70
+281.1%
Avg target
Bull Case
$22.80
+453.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$179.19
-97.7% from high
52-Week Low
$3.45
+19.4% from low
Target vs 52W High
$15.70
-91.2% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |